» Articles » PMID: 36117978

The Multifaceted Phenotypic and Genotypic Spectrum of Type-IV-collagen-related Nephropathy-A Human Genetics Department Experience

Abstract

Disease-causing variants in 5 are associated with type-IV-collagen-related nephropathy, a genetically and phenotypically multifaceted disorder comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) and autosomal, X-linked and a proposed digenic inheritance. Initial symptoms of individuals with AS are microscopic hematuria followed by proteinuria leading to kidney failure (90% on dialysis < age 40 years). In contrast, individuals with TBMN, an outdated histology-derived term, present with microscopic hematuria, only some of them develop kidney failure (>50 years of age). An early diagnosis of type-IV-collagen-related nephropathy is essential for optimized therapy and slowing of the disease. Sixty index cases, in whom exome sequencing had been performed and with disease-causing variant(s) in , were evaluated concerning their clinical tentative diagnosis and their genotype. Of 60 reevaluated individuals with type-IV-collagen-related nephropathy, 72% had AS, 23% TBMN and 5% focal segmental glomerulosclerosis (FSGS) as clinical tentative diagnosis. The FSGS cases had to be re-classified as having type-IV-collagen-related nephropathy. Twelve percent of cases had AS as clinical tentative diagnosis and a monoallelic disease-causing variant in but could not be classified as autosomal dominant AS because of limited or conflicting clinical data. This study illustrates the complex clinical and genetic picture of individuals with a type IV-collagen-related nephropathy indicating the need of a refined nomenclature and the more interdisciplinary teamwork of clinicians and geneticists as the key to optimized patient care.

Citing Articles

Type IV collagen-related nephropathy as a diagnosis in nephrotic syndrome.

Dotis J, Ververi A, Printza N Pediatr Nephrol. 2024; 40(3):873.

PMID: 39377939 DOI: 10.1007/s00467-024-06549-5.


Case report: A novel compound heterozygous variant in the gene was identified in a patient with autosomal recessive Alport syndrome.

Chen S, Zhang Y, He J, Yang D Front Genet. 2024; 15:1426806.

PMID: 39071776 PMC: 11272558. DOI: 10.3389/fgene.2024.1426806.


Hidden genetics behind glomerular scars: an opportunity to understand the heterogeneity of focal segmental glomerulosclerosis?.

Mitrotti A, Giliberti M, Di Leo V, di Bari I, Pontrelli P, Gesualdo L Pediatr Nephrol. 2023; 39(6):1685-1707.

PMID: 37728640 PMC: 11026212. DOI: 10.1007/s00467-023-06046-1.

References
1.
Hudson B, Tryggvason K, Sundaramoorthy M, Neilson E . Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003; 348(25):2543-56. DOI: 10.1056/NEJMra022296. View

2.
Savige J . Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous or Variant?. Kidney Int Rep. 2018; 3(6):1239-1241. PMC: 6224634. DOI: 10.1016/j.ekir.2018.08.002. View

3.
Bekheirnia M, Reed B, Gregory M, McFann K, Shamshirsaz A, Masoumi A . Genotype-phenotype correlation in X-linked Alport syndrome. J Am Soc Nephrol. 2010; 21(5):876-83. PMC: 2865738. DOI: 10.1681/ASN.2009070784. View

4.
Rheault M . Women and Alport syndrome. Pediatr Nephrol. 2011; 27(1):41-6. PMC: 3223569. DOI: 10.1007/s00467-011-1836-7. View

5.
Cangiotti A, Sessa A, Meroni M, Montironi R, Ragaiolo M, Mambelli V . Evolution of glomerular basement membrane lesions in a male patient with Alport syndrome: ultrastructural and morphometric study. Nephrol Dial Transplant. 1996; 11(9):1829-34. View